141 related articles for article (PubMed ID: 34905383)
1. Lead Optimization of Influenza Virus RNA Polymerase Inhibitors Targeting PA-PB1 Interaction.
Mizuta S; Otaki H; Ishikawa T; Makau JN; Yamaguchi T; Fujimoto T; Takakura N; Sakauchi N; Kitamura S; Nono H; Nishi R; Tanaka Y; Takeda K; Nishida N; Watanabe K
J Med Chem; 2022 Jan; 65(1):369-385. PubMed ID: 34905383
[TBL] [Abstract][Full Text] [Related]
2. Discovery and synthesis of novel benzofurazan derivatives as inhibitors of influenza A virus.
Kessler U; Castagnolo D; Pagano M; Deodato D; Bernardini M; Pilger B; Ranadheera C; Botta M
Bioorg Med Chem Lett; 2013 Oct; 23(20):5575-7. PubMed ID: 24012120
[TBL] [Abstract][Full Text] [Related]
3. Structure-based virtual screening of influenza virus RNA polymerase inhibitors from natural compounds: Molecular dynamics simulation and MM-GBSA calculation.
Jin Z; Wang Y; Yu XF; Tan QQ; Liang SS; Li T; Zhang H; Shaw PC; Wang J; Hu C
Comput Biol Chem; 2020 Apr; 85():107241. PubMed ID: 32120300
[TBL] [Abstract][Full Text] [Related]
4. A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits.
Massari S; Nannetti G; Desantis J; Muratore G; Sabatini S; Manfroni G; Mercorelli B; Cecchetti V; Palù G; Cruciani G; Loregian A; Goracci L; Tabarrini O
J Med Chem; 2015 May; 58(9):3830-42. PubMed ID: 25856229
[TBL] [Abstract][Full Text] [Related]
5. Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance.
Nannetti G; Massari S; Mercorelli B; Bertagnin C; Desantis J; Palù G; Tabarrini O; Loregian A
Antiviral Res; 2019 May; 165():55-64. PubMed ID: 30885750
[TBL] [Abstract][Full Text] [Related]
6. Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase.
Muratore G; Goracci L; Mercorelli B; Foeglein Á; Digard P; Cruciani G; Palù G; Loregian A
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6247-52. PubMed ID: 22474359
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction.
D'Agostino I; Giacchello I; Nannetti G; Fallacara AL; Deodato D; Musumeci F; Grossi G; Palù G; Cau Y; Trist IM; Loregian A; Schenone S; Botta M
Eur J Med Chem; 2018 Sep; 157():743-758. PubMed ID: 30142611
[TBL] [Abstract][Full Text] [Related]
8. 4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling.
Trist IM; Nannetti G; Tintori C; Fallacara AL; Deodato D; Mercorelli B; Palù G; Wijtmans M; Gospodova T; Edink E; Verheij M; de Esch I; Viteva L; Loregian A; Botta M
J Med Chem; 2016 Mar; 59(6):2688-703. PubMed ID: 26924568
[TBL] [Abstract][Full Text] [Related]
9. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
Yuan S; Chu H; Zhao H; Zhang K; Singh K; Chow BK; Kao RY; Zhou J; Zheng BJ
Antiviral Res; 2016 Jan; 125():34-42. PubMed ID: 26593979
[TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus inhibitor AL18 also possesses activity against influenza A and B viruses.
Muratore G; Mercorelli B; Goracci L; Cruciani G; Digard P; Palù G; Loregian A
Antimicrob Agents Chemother; 2012 Nov; 56(11):6009-13. PubMed ID: 22908168
[TBL] [Abstract][Full Text] [Related]
11. Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.
Wunderlich K; Mayer D; Ranadheera C; Holler AS; Mänz B; Martin A; Chase G; Tegge W; Frank R; Kessler U; Schwemmle M
PLoS One; 2009 Oct; 4(10):e7517. PubMed ID: 19841738
[TBL] [Abstract][Full Text] [Related]
12. The PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses.
Jones JC; Marathe BM; Vogel P; Gasser R; Najera I; Govorkova EA
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193653
[TBL] [Abstract][Full Text] [Related]
13. 1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors.
Pismataro MC; Felicetti T; Bertagnin C; Nizi MG; Bonomini A; Barreca ML; Cecchetti V; Jochmans D; De Jonghe S; Neyts J; Loregian A; Tabarrini O; Massari S
Eur J Med Chem; 2021 Oct; 221():113494. PubMed ID: 33962311
[TBL] [Abstract][Full Text] [Related]
14. Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly.
Massari S; Nannetti G; Goracci L; Sancineto L; Muratore G; Sabatini S; Manfroni G; Mercorelli B; Cecchetti V; Facchini M; Palù G; Cruciani G; Loregian A; Tabarrini O
J Med Chem; 2013 Dec; 56(24):10118-31. PubMed ID: 24313730
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel inhibitor against endonuclease subunit of Influenza pH1N1 polymerase: A combined molecular docking, molecular dynamics, MMPBSA, QMMM and ADME studies to combat influenza A viruses.
Mohseni SS; Nasri F; Davari K; Mirzaie S; Moradzadegan A; Abdi F; Farzaneh F
Comput Biol Chem; 2018 Dec; 77():279-290. PubMed ID: 30396155
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Influenza Polymerase PA-PB1 Interaction Inhibitors Using an
Zhang J; Hu Y; Wu N; Wang J
ACS Chem Biol; 2020 Jan; 15(1):74-82. PubMed ID: 31714745
[TBL] [Abstract][Full Text] [Related]
17. Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening.
Lo CY; Li OT; Tang WP; Hu C; Wang GX; Ngo JC; Wan DC; Poon LL; Shaw PC
Sci Rep; 2018 Feb; 8(1):2280. PubMed ID: 29396435
[TBL] [Abstract][Full Text] [Related]
18. Non-chelating p-phenylidene-linked bis-imidazoline analogs of known influenza virus endonuclease inhibitors: Synthesis and anti-influenza activity.
Dar'in D; Zarubaev V; Galochkina A; Gureev M; Krasavin M
Eur J Med Chem; 2019 Jan; 161():526-532. PubMed ID: 30390440
[TBL] [Abstract][Full Text] [Related]
19. A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In Vitro.
Jones JC; Marathe BM; Lerner C; Kreis L; Gasser R; Pascua PN; Najera I; Govorkova EA
Antimicrob Agents Chemother; 2016 Sep; 60(9):5504-14. PubMed ID: 27381402
[TBL] [Abstract][Full Text] [Related]
20. Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction.
Watanabe K; Ishikawa T; Otaki H; Mizuta S; Hamada T; Nakagaki T; Ishibashi D; Urata S; Yasuda J; Tanaka Y; Nishida N
Sci Rep; 2017 Aug; 7(1):9500. PubMed ID: 28842649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
